Welcome to AMYPAD!

We are a collaborative research initiative aiming to improve the understanding, diagnosis and management of Alzheimer’s disease through the utilisation of ß-amyloid PET imaging.

The Amyloid imaging to prevent Alzheimer’s disease (AMYPAD) initiative aims to:

Homepage Image Neuraceq™ (left) and Vizamyl™ (right). Upper images: amyloid negative scans. Lower images: amyloid positive scans.
Latest News
New AMYPAD page on Zenodo to share project's outputs
New AMYPAD page on Zenodo to share project's outputs 07 May 2021 Zenodo is used as an online repository for all AMYPAD scientific publications......
The AMYPAD project has been extended for an additional year
The AMYPAD project has been extended for an additional year 05 May 2021 IMI has officially approved our request for an extension in order to ensure the full delivery of the project objectives, within the original financial resources......
Recruitment update
Recruitment update 03 May 2021 AMYPAD PHNS: currently 951 participants recruited of which 766 have been scanned......
Recruitment status (as 3 May, 2021)
Recruitment status (as 3 May, 2021)